MODES Trademark

Trademark Overview

On Wednesday, April 14, 2021, a trademark application was filed for MODES with the United States Patent and Trademark Office. The USPTO has given the MODES trademark a serial number of 90644061. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, July 23, 2024. This trademark is owned by Biohaven Therapeutics Ltd.. The MODES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Discovery in the nature of pharmaceutical research, development, engineering and testing, namely, for multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders
modes

General Information

Serial Number90644061
Word MarkMODES
Filing DateWednesday, April 14, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, July 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 11, 2022

Trademark Statements

Goods and ServicesDiscovery in the nature of pharmaceutical research, development, engineering and testing, namely, for multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 21, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBiohaven Therapeutics Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRoad Town, Tortola VG1110
VG
Party NameBiohaven Therapeutics Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNew Haven, CT 06510

Trademark Events

Event DateEvent Description
Wednesday, July 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 17, 2021NEW APPLICATION ENTERED
Wednesday, December 8, 2021EXAMINERS AMENDMENT -WRITTEN
Monday, December 6, 2021ASSIGNED TO EXAMINER
Wednesday, December 8, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, December 8, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, December 8, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, December 9, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 22, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 11, 2022PUBLISHED FOR OPPOSITION
Tuesday, January 11, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 8, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 8, 2022SOU TEAS EXTENSION RECEIVED
Thursday, September 8, 2022SOU EXTENSION 1 FILED
Thursday, September 8, 2022SOU EXTENSION 1 GRANTED
Saturday, September 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 1, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, March 1, 2023SOU EXTENSION 2 FILED
Wednesday, March 1, 2023SOU EXTENSION 2 GRANTED
Friday, March 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 17, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 17, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 17, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, September 7, 2023TEAS REQUEST TO DIVIDE RECEIVED
Thursday, September 7, 2023DIVISIONAL REQUEST RECEIVED
Thursday, September 7, 2023SOU EXTENSION 3 FILED
Thursday, September 7, 2023SOU TEAS EXTENSION RECEIVED
Friday, September 15, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 18, 2023DIVISIONAL PROCESSING COMPLETE
Monday, September 18, 2023SOU EXTENSION 3 GRANTED
Tuesday, September 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 19, 2023CORRECTED NOA E-MAILED
Thursday, January 25, 2024SOU TEAS EXTENSION RECEIVED
Thursday, January 25, 2024SOU EXTENSION 4 FILED
Thursday, January 25, 2024SOU EXTENSION 4 GRANTED
Saturday, January 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 23, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 23, 2024SOU EXTENSION 5 FILED
Tuesday, July 23, 2024SOU EXTENSION 5 GRANTED
Wednesday, July 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

modes disorders diseases treatment autoimmune degradation lysosomal target them neurological inflammatory